Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Meropenem-Resistant Pseudomonas Aeruginosa Isolates

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02969-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Clinical Isolates of Enterobacteriaceae and Pseudomonas Aeruginosa: Results From a Multicenter Study in China, 2017

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Evaluation of theIn VitroActivity of Meropenem-Vaborbactam Against Clinical Isolates of KPC-PositiveEnterobacteriaceae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Effects of Klebsiella Pneumoniae Carbapenemase Subtypes, Extended-Spectrum Β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam Against Carbapenem-Resistant K. Pneumoniae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Molecular Epidemiology of Beta-Lactamases in Ceftazidime-Resistant Pseudomonas Aeruginosa Isolates

Mikrobiyoloji Bulteni
MedicineInfectious DiseasesImmunologyMicrobiologyMicrobiology
2015English

Comparative in Vitro and in Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam Against Pseudomonas Aeruginosa

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

What Is the Role of the New Β-Lactam/Β-Lactamase Inhibitors Ceftolozane/Tazobactam and Ceftazidime/Avibactam?

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2016English

Emergence of Ceftolozane-Tazobactam Resistant Pseudomonas Aeruginosa During Treatment Is Mediated by a Single AmpC Structural Mutation

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy